Oncopeptides AB (publ) (STO:ONCO)
Sweden
· Delayed Price · Currency is SEK 5.35
+0.10 (1.90%)
At close: Dec 5, 2025
Oncopeptides AB Revenue
Oncopeptides AB had revenue of 20.21M SEK in the quarter ending September 30, 2025, with 137.62% growth. This brings the company's revenue in the last twelve months to 62.47M, up 130.75% year-over-year. In the year 2024, Oncopeptides AB had annual revenue of 31.65M, down -10.14%.
Revenue (ttm)
62.47M
Revenue Growth
+130.75%
P/S Ratio
23.36
Revenue / Employee
832.87K
Employees
80
Market Cap
1.46B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 27.85B |
| Getinge AB | 35.85B |
| Sectra AB | 3.37B |
| Camurus AB | 2.35B |
| Medicover AB | 25.67B |
| Asker Healthcare Group AB | 16.41B |
| BioArctic AB | 1.92B |
| AddLife AB | 10.53B |
Oncopeptides AB News
- 24 days ago - Oncopeptides AB (FRA:OND) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amid Strategic ... - GuruFocus
- 24 days ago - Q3 2025 Oncopeptides AB Earnings Call Transcript - GuruFocus
- 4 weeks ago - Oncopeptides AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Oncopeptides AB (publ) (ONPPF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market ... - GuruFocus
- 1 year ago - Q3 2024 Oncopeptides AB Earnings Call Transcript - GuruFocus
- 1 year ago - Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and ... - GuruFocus
- 1 year ago - Q2 2024 Oncopeptides AB Earnings Call Transcript - GuruFocus